Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 08, 2021 8:59pm
190 Views
Post# 32508673

RE:Company warrants

RE:Company warrantsWt warrants expire June 2023 they are 8:1 meaning you need to buy 8 warrants to exercise for 1 share exercise price is 0.72 so at 0.08 you need 8 for 0.64 and exercise at 0.72 for 1.36  there are just under 80 million outstanding 

ws warrants expire dec 2023 are 1:1 at exercise at 1.10.   There are just under 5 million outstanding 



NoGambleNoFutur wrote: Hey guys, I'm very aware of what warrants are and how they work, but I'm having a hard time following the ones of this company. Can someone please explain to me the difference between the WT and WS warrants? Also, I read somewhere that the WT warrants expire in December 2023, but my platform says June 2023. Can someone just confirm to me the exercise price, expiration date, and when we can exercise WT warrants? If you have all this info and can share it on this post, I would really appreciate it. Thanks.


<< Previous
Bullboard Posts
Next >>